The Essential Medicinal Chemistry of Curcumin
Open accessThe DOI matches its Crossref record; 151 of the 153 references it cites were found in a registry or an index.
Abstract
Curcumin is a constituent (up to ∼5%) of the traditional medicine known as turmeric. Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation. Curcumin has recently been classified as both a PAINS (pan-assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate. The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases. No double-blinded, placebo controlled clinical trial of curcumin has been successful. This manuscript reviews the essential medicinal chemistry of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead. On the basis of this in-depth evaluation, potential new directions for research on curcuminoids are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One mechanism by which polyphenols could exert protective properties is by generation of a hormetic response to their use85–88.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In vivo use of polyphenols (especially curcumin) in some mouse models of AD has been successful77,87, but this has not (yet) been translated to usefulness in human AD2,70,87,88.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Tomita, M., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Takasu, N., Matsuda, T., Ohta, T., Tanaka, Y., & Mori, N. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.08.004 · Cited by 55
RetractedKundu, P., Mohanty, C., & Sahoo, S. K. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.03.048 · Cited by 51
RetractedDilnawaz, F., Singh, A., & Sahoo, S. K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.10.022 · Cited by 33
RetractedSeely, K. A., Levi, M. S., & Prather, P. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151654 · Cited by 21
RetractedNi, Z., Xing, F., Wang, P., & Cao, G. (2007) · Applied Clay Science · doi:10.1016/j.clay.2007.07.008 · Cited by 20
RetractedPrather, P. L., Seely, K. A., & Levi, M. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)45583-3 · Cited by 3
RetractedGlutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“136 However, the extremely long incubation times reported here would require follow-up to exclude the likely possibility of aggregation or degradation in the assay conditions.”
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Research works printed but not linked: 4
- 2. Hanson M. Is the 2015 Nobel Prize a turning point for traditional Chinese medicine? https://theconversation.com/is-the-2015-nobel-prize-a-turning-point-for-traditional-chinese-medicine-48643 (accessed June 6, 2016). · DOI
- 10. Elias G.; Jacob P. J.; Hareeshbabu E.; Mathew V. B.; Krishnan B.; Krishnakumar K. Curcumin: Transforming the spice to a wonder drug. Int. J. Pharm. Sci. Res. 2015, 6, 2671– 2680. 10.13040/IJPSR.0975-8232.6(7).2671-80. · doi:10.13040/ijpsr.0975-8232.6(7).2671-80
- 35. Majeed S. The state of the curcumin market. Natural Products Insider; Informa Exhibitions, 2015; http://www.naturalproductsinsider.com/articles/2015/12/the-state-of-the-curcumin-market.aspx.
- 36. Niranjan A.; Prakash D. Chemical constituents and biological activities of turmeric (Curcuma longa l.) - a review. J. Food Sci. Technol. (New Delhi, India) 2008, 45, 109– 116.
Cited by
Items 101–200 of 1,003
Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy
Škubník, J., Pavlíčková, V. S., Ruml, T., & Rimpelová, S. (2021) · Plants · doi:10.3390/plants10030569 · Cited by 125
Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights
Jacob, S., Kather, F. S., Morsy, M. A., Boddu, S. H. S., Attimarad, M., Shah, J., Shinu, P., & Nair, A. B. (2024) · Nanomaterials · doi:10.3390/nano14080672 · Cited by 125
“…challenges associated with curcumin, including limited bioavailability, insufficient distribution within tissues, rapid clearance, chemical degradation, and toxic potential, have resulted in its categorization as a pan-assay interference compound as well as a failed metabolic panacea molecule [15].”
BackgroundInfluentialRecent developments with rhodanine as a scaffold for drug discovery
Kaminskyy, D. V., Kryshchyshyn‐Dylevych, A., & Lesyk, R. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1388370 · Cited by 126
“This suggests that any report of activity in an assay that does not either exclude or account for these potential modes of assay interference should be treated with caution [165].”
BackgroundSaber‐Moghaddam, N., Salari, S., Hejazi, S., Amini, M., Taherzadeh, Z., Eslami, S., Rezayat, S. M., Jaafari, M. R., & Elyasi, S. (2021) · Phytotherapy Research · doi:10.1002/ptr.7004 · Cited by 130
Advanced Strategies for Modulation of the Material–Macrophage Interface
Huyer, L. D., Pascual‐Gil, S., Wang, Y., Mandla, S., Yee, B., & Radisic, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909331 · Cited by 127
Kaye, K. O., Paprottka, F. J., Escudero, R., Casabona, G., Montes, J., Fakin, R. M., Moke, L., Stasch, T., Richter, D. F., & Benito-Ruiz, J. (2020) · Aesthetic Plastic Surgery · doi:10.1007/s00266-020-01752-9 · Cited by 128
The role of natural products in revealing NRF2 function
Zhang, D. D., & Chapman, E. (2020) · Natural Product Reports · doi:10.1039/c9np00061e · Cited by 124
Curcumin nanoformulations: Beneficial nanomedicine against cancer
Dizaj, S. M., Alipour, M., Abdolahinia, E. D., Ahmadian, E., Eftekhari, A., Forouhandeh, H., Saadat, Y. R., Sharifi, S., & Vahed, S. Z. (2022) · Phytotherapy Research · doi:10.1002/ptr.7389 · Cited by 128
Moniruzzaman, M., & Min, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050447 · Cited by 122
“However, no form of curcumin or its closely related analogues poses the properties required for a good drug or additive candidate in terms of chemical stability, high water solubility, potent and selective target activity, high bioavailability, broad tissue distribution, stable metabolism and low toxicity [53].”
BackgroundHow drug repurposing can advance drug discovery: challenges and opportunities
Pinzi, L., Bisi, N., & Rastelli, G. (2024) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2024.1460100 · Cited by 135
“Initially used as a food spice, curcumin has recently gained attention for its anti-in fl ammatory, antioxidant, antitumor and neuroprotective activities (Wilken et al., 2011; Nelson et al., 2017).”
Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule?
Serafini, M. M., Catanzaro, M., Rosini, M., Racchi, M., & Lanni, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.004 · Cited by 129
“Curcumin has numerous PAINS-type characteristics such as redox activity, metal chelation properties, auto-fluorescence and covalent protein labeling [34].”
BackgroundDiscovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches
Hu, W., Huang, X., Wu, J., Yang, L. Y. O., Zheng, Y., Shen, Y., Li, Z., & Li, X. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01202 · Cited by 121
Small molecules in the treatment of COVID-19
Lei, S., Chen, X., Wu, J., Duan, X., & Men, K. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01249-8 · Cited by 125
“Curcumin, a betadiketone, is a natural dyestuff found in the root of Curcuma longa.(588) As a broad-spectrum antiviral drug, curcumin can not only treat HIV virus, liver poison, and influenza A virus but has also been recognized as a therapeutic agent for COVID-19 as it affects cellular posttranscriptional and posttra…”
BackgroundNatural Extracts for Antibacterial Applications
Chen, C., Chen, L., Mao, C., Jin, L., Wu, S., Zheng, Y., Cui, Z., Li, Z., Zhang, Y., Zhu, S., et al. (2023) · Small · doi:10.1002/smll.202306553 · Cited by 131
Halegoua-DeMarzio, D., Navarro, V., Ahmad, J., Avula, B., Barnhart, H., Barritt, A. S., Bonkovsky, H. L., Fontana, R. J., Ghabril, M. S., Hoofnagle, J. H., et al. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.09.026 · Cited by 119
Feng, S., Sun, Y., Wang, D., Sun, P., & Shao, P. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116970 · Cited by 119
Regulation and therapy, the role of JAK2/STAT3 signaling pathway in OA: a systematic review
Chen, B., Ning, K., Sun, M., & Zhang, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01094-4 · Cited by 122
“Curcumin not only activated monocytes and macrophages and released lysozyme by inhibiting MCP-1, but also upregulated monocyte and macrophage adhesion molecules and IL-1 and IL-6 levels [74].”
BackgroundThe Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway
Zoi, V., Kyritsis, A. P., Galani, V., Lazari, D. M., Sioka, C., Voulgaris, S., & Alexiou, G. Α. (2024) · Cancers · doi:10.3390/cancers16081554 · Cited by 124
“Moreover curcumin is unstable in the presence of light, and quick photochemical degradation occurs when solid or soluble curcumin is exposed to light [18,19].”
Backgroundde Lima, E. P., Laurindo, L. F., Catharin, V. C. S., Direito, R., Tanaka, M., Jasmin Santos German, I., Lamas, C. B., Guiguer, E. L., Araújo, A. C., Fiorini, A. M. R., et al. (2025) · Metabolites · doi:10.3390/metabo15020124 · Cited by 94
Therapeutic potential of curcumin for multiple sclerosis
Qureshi, M., Al-Suhaimi, E. A., Wahid, F., Shehzad, O., & Shehzad, A. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3149-5 · Cited by 124
“Curcumin is hindered by low bioavailability, known mechanism of action, chemical stability, and absorption, distribution, metabolism, excretion, and toxicology (ADMET) [76].”
BackgroundApplications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure
Jin, Y., Wang, H., Yi, K., Lv, S., Hu, H., Li, M., & Tao, Y. (2021) · Nano-Micro Letters · doi:10.1007/s40820-020-00550-x · Cited by 111
Alves, R. C., Fernandes, R. P., Fonseca‐Santos, B., Victorelli, F. D., & Chorilli, M. (2018) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2018.1489216 · Cited by 118
“A recent report by chemists has cast doubt on the effects of CCM.[9] Specifically, CCM’s stability in assay media presents problems.”
BackgroundInfluentialCurcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways
Jin, T., Zhang, Y., Botchway, B. O. A., Zhang, J., Fan, R., Zhang, Y., & Liu, X. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113091 · Cited by 122
Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin
Umerska, A. M., Gaucher, C., Oyarzun-Ampuero, F. A., Fries, I., Colin, F., Villamizar‐Sarmiento, M. G., Maincent, P., & Sapin‐Minet, A. (2018) · Antioxidants · doi:10.3390/antiox7040046 · Cited by 117
“The drawbacks of curcumin, such as low bioavailability, poor tissue distribution, extensive metabolism, chemical instability and potential for toxicity [9], have led to its classification as both a PAINS (pan-assay interference compound) and an IMPS (invalid metabolic panaceas) candidate.”
BackgroundVanreppelen, G., Wuyts, J., Dijck, P. V., & Vandecruys, P. (2023) · Journal of Fungi · doi:10.3390/jof9020171 · Cited by 130
Metcalfe, R. D., Putoczki, T. L., & Griffin, M. D. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01424 · Cited by 130
“However, the use of curcumin as a drug candidate or treatment is controversial (246, 249).”
BackgroundMethodDegot, P., Huber, V., Hofmann, E., Hahn, M. W., Touraud, D., & Kunz, W. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.127660 · Cited by 118
Ai, S., Li, Y., Zheng, H., Zhang, M., Tao, J., Liu, W., Peng, L., Wang, Z., & Wang, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02426-3 · Cited by 123
“Furthermore, these herbal extracts are considered essential sources for new drug development because of their diverse compounds with unique structures and considerable biological activities [17, 179].”
BackgroundMicroencapsulation of curcumin by spray drying and freeze drying
Guo, J., Li, P., Kong, L., & Xu, B. (2020) · LWT · doi:10.1016/j.lwt.2020.109892 · Cited by 127
Basic principles of drug delivery systems – the case of paclitaxel
Ezrahi, S., Aserin, A., & Garti, N. (2018) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2018.11.004 · Cited by 121
Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1320-y · Cited by 123
“Through the activation of PPARγ, curcumin inhibits tumor growth by downregulating cyclin D1 and EGFR expression [174].”
BackgroundCurcumin combined with photodynamic therapy, promising therapies for the treatment of cancer
Xie, L., Ji, X., Zhang, Q., & Wei, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112567 · Cited by 120
Antiaging agents: safe interventions to slow aging and healthy life span extension
Liu, J.-K. (2022) · Natural Products and Bioprospecting · doi:10.1007/s13659-022-00339-y · Cited by 105
“Recently, an excellent review discussed an in-depth evaluation of curcumin, a potential new direction for research [30].”
BackgroundLimaye, A., Yu, R., Chou, C., Liu, J., & Cheng, K. (2018) · Toxins · doi:10.3390/toxins10010025 · Cited by 119
“Curcumin makes up to 60–70% of the curcuminoid crude extract by weight [76].”
BackgroundImproving natural product research translation: From source to clinical trial
Sorkin, B. C., Kuszak, A. J., Bloss, G., Fukagawa, N. K., Hoffman, F. A., Jafari, M., Barrett, B. P., Brown, P. N., Bushman, F. D., Casper, S. J., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201902143r · Cited by 121
Self-citationTargeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy
Mirza‐Aghazadeh‐Attari, M., Ekrami, E., Mousavi‐Aghdas, S. A., Mihanfar, A., Hallaj, S., Yousefi, B., Safa, A., & Majidinia, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117481 · Cited by 116
Curcumin and endometriosis: Review on potential roles and molecular mechanisms
Arablou, T., & Kolahdouz‐Mohammadi, R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.119 · Cited by 123
Zheng, J., Cheng, J., Zheng, S., Feng, Q., & Xiao, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00472 · Cited by 109
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
Dahlin, J. L., Nelson, K. M., Strasser, J. M., Baršytė-Lovejoy, D., Szewczyk, M. M., Organ, S. L., Cuellar, M. E., Singh, G., Shrimp, J. H., Nguyen, N. H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01657-3 · Cited by 113
Self-citationMultifunctional Curcumin Mediate Multitherapeutic Effects
Shehzad, A., Qureshi, M., Anwar, M. N., & Lee, Y. S. (2017) · Journal of Food Science · doi:10.1111/1750-3841.13793 · Cited by 117
Ghosh, S. S., He, H., Wang, J., Gehr, T. W., & Ghosh, S. (2018) · Tissue Barriers · doi:10.1080/21688370.2018.1425085 · Cited by 106
Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation
Shao, B., Wang, S., Pan, P., Yao, J., Wu, K., Li, Z., Bai, Y., & Linghu, E. (2019) · Inflammation · doi:10.1007/s10753-019-01008-y · Cited by 110
“Curcumin is a kind of hyderophobic polyphenol derived from turmeric, which is a traditional Indian spice [111].”
BackgroundBorges, G. Á., Elias, S. T., Amorim, B. R., de Lima, C. L., Coletta, R. D., CASTILHO, R. M., SQUARIZE, C. H., & Guerra, E. N. S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6780 · Cited by 109
“…potential of curcumin and other curcuminoids has been thoroughly described, even though concerns regarding their stability, solubility, and bioavailability have been raised, chiefly motivated by the lack of successful results from controlled clinical trials, as reviewed by Nelson et al. (2017).”
BackgroundHussain, Y., Islam, L., Khan, H. Z., Filosa, R., Aschner, M., & Javed, S. (2021) · Phytotherapy Research · doi:10.1002/ptr.7225 · Cited by 113
“within heptadienedione system, predominantly through alcohol dehydrogenase interaction (Nelson et al., 2017).”
BackgroundZhang, X., Ma, Y., Ma, L., Zu, M., Song, H., & Xiao, B. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115126 · Cited by 106
Mokgalaboni, K., Ntamo, Y., Ziqubu, K., Nyambuya, T. M., Nkambule, B. B., Mazibuko-Mbeje, S. E., Gabuza, K., Chellan, N., Tiano, L., & Dludla, P. V. (2021) · Food & Function · doi:10.1039/d1fo02696h · Cited by 115
Makuch, S., Więcek, K., & Woźniak, M. (2021) · Pharmaceuticals · doi:10.3390/ph14040309 · Cited by 112
“Under physiological conditions, curcumin is prone to undergo degradation via solvolysis and autoxidation, reduction by various enzymes and conjugation (glucuronidation or sulfonation), leading to loss of native values and being eliminated from the system [25,26,29].”
BackgroundYang, R., Zheng, Y., Wang, Q., & Zhao, L. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2759-z · Cited by 107
Curcumin Activates ROS Signaling to Promote Pyroptosis in Hepatocellular Carcinoma HepG2 Cells
Liang, W., Gong, Y.-X., Li, H., Sun, F., LI, W.-L., Chen, D., XIE, D.-P., Ren, C., Guo, X., Wang, Z., et al. (2021) · In Vivo · doi:10.21873/invivo.12253 · Cited by 99
Li, N., Wang, Q., Zhou, J., Li, S., Liu, J., & Chen, H. (2022) · Molecules · doi:10.3390/molecules27103291 · Cited by 109
“In fact, there are some debates about the biological activity of curcumin because it is an unstable, reactive, nonbioavailable compound, which is also considered a PAINS medication [260].”
BackgroundKim, J. H., Verwilst, P., Won, M., Lee, J., Sessler, J. L., Han, J., & Kim, J. S. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03875 · Cited by 98
Effects of Curcumin on Vessel Formation Insight into the Pro- and Antiangiogenesis of Curcumin
Wang, T., & Chen, J. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/1390795 · Cited by 108
“Besides, turmeric preparations could be applied to treat fresh wounds and anticancer effect of turmeric was also documented in Indian medical literature [24].”
BackgroundDevelopment of active edible films made from banana starch and curcumin-loaded nanoemulsions
Sánchez, L. T., Pinzón, M. I., & Villa, C. C. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.131121 · Cited by 100
The photoactivity of natural products – An overlooked potential of phytomedicines?
Siewert, B., & Stuppner, H. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152985 · Cited by 96
Curcumin as tyrosine kinase inhibitor in cancer treatment
Golonko, A., Lewandowska, H., Świsłocka, R., Jasińska, U., Priebe, W., & Lewandowski, W. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.015 · Cited by 100
Design and Characterization of Spray-Dried Proliposomes for the Pulmonary Delivery of Curcumin
Adel, I. M., Elmeligy, M. R., Abdelrahim, M. E. A., Maged, A., Abdelkhalek, A. A., Abdelmoteleb, A., & ElKasabgy, N. A. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s306831 · Cited by 97
“25°C), high photosensitivity, rapid in vivo metabolism and poor cellular uptake severely limit its bioavailability.(13,19) Encapsulation of curcumin within liposomes seemed to”
BackgroundInnovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations
Yakubu, J., & Pandey, A. V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050637 · Cited by 106
“Additionally, some studies suggest potential toxicity at very high doses or with long-term use [43].”
BackgroundThe functional genomic studies of curcumin
Huminiecki, Ł., Horbańczuk, J. O., & Atanasov, A. G. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.002 · Cited by 103
Azhdari, M., Karandish, M., & Mansoori, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6323 · Cited by 96
“…is a traditional medicinal plant that is used extensively in domestic use and its application to improve the taste and color and therapeutic properties (Nelson et al., 2017) without any toxicity in oral administration © 2019 John Wiley & Sons, Ltd.com/journal/ptr 1289 (Soleimani et al., 2018).”
BackgroundYang, K., Chen, J., Zhang, T., Yuan, X., Ge, A., Wang, S., Xu, H., Zeng, L., & Ge, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949746 · Cited by 113
“Curcumin is a natural phenolic antioxidant extracted from the rhizomes of ginger plants such as turmeric, curcuma, mustard, curry, and turmeric, and the main chain is unsaturated aliphatic and aromatic groups (107).”
BackgroundToma, L., Sanda, G. M., Niculescu, L. S., Deleanu, M., Sima, A. V., & Stancu, C. S. (2020) · Biomolecules · doi:10.3390/biom10040641 · Cited by 103
Curcumin nanoformulations to combat aging-related diseases
Mahjoob, M., & Stochaj, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101364 · Cited by 98
Chen, M., Tan, A.-H., & Li, J. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2139398 · Cited by 100
Huang, Q., Zhong, Y., Dong, H., Zheng, Q., Shi, S., Zhu, K., Qu, X., Hu, W., Zhang, X., & Wang, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111922 · Cited by 91
Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
Shemiakova, T. S., Ivanova, E. A., Grechko, A. V., Герасимова, Е. В., Sobenin, I. A., & Orekhov, A. N. (2020) · Biomedicines · doi:10.3390/biomedicines8060166 · Cited by 98
“It should be noted, however, that dietary curcumin has relatively low bioavailability, so preparations with improved properties are needed for attaining better effects [76].”
BackgroundEffects of Turmeric ( Curcuma longa) Extract in streptozocin‐induced diabetic model
Essa, R., Sadek, A. E., Baset, M. E., Rawash, M. A., Sami, D. G., Badawy, M. T., Mansour, M. E., Attia, H., Saadeldin, M. K., & Abdellatif, A. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.12988 · Cited by 105
Dietary supplements for treatment of endometriosis: A review.
Bahat, P. Y., Ayhan, I., Özdemir, E. Ü., Inceboz, U. S., & Oral, E. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i1.11237 · Cited by 105
Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Aranda‐Rivera, A. K., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., & Scholze, A. (2022) · Antioxidants · doi:10.3390/antiox11061112 · Cited by 102
“Curcuminoids account for only around 1 to 6 percent of Curcuma longa extracts, and curcumin is one of those curcuminoids [171].”
BackgroundNaturally Occurring PCSK9 Inhibitors
Adorni, M. P., Zimetti, F., Lupo, M. G., Ruscica, M., & Ferri, N. (2020) · Nutrients · doi:10.3390/nu12051440 · Cited by 92
“In particular, curcumin presents a poor stability under physiological conditions, with a t1/2 of less than 10 min [127].”
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
Huang, M., Zhai, B., Fan, Y. B., Sun, J., Shi, Y., Zhang, X., Zou, J., Wang, J., & Guo, D. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s410688 · Cited by 95
“In alkaline buffered aqueous solutions, solvolysis of the heptadienone chain leads to degradation of 90% of CUR, yielding products such as vanillin, ferulic acid, and ferulic aldehyde.(38,39) CUR undergoes autoxidation through a chain of free radical reactions, binding to oxygen and yielding dicyclopentadiene products.”
BackgroundPandolfi, L., Bellini, M., Vanna, R., Morasso, C., Zago, A. S., Carcano, S., Avvakumova, S., Bertolini, J. A., Rizzuto, M. A., Colombo, M., et al. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00974 · Cited by 95
Rivera-Mancía, S., Trujillo, J., & Pedraza‐Chaverrí, J. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.05.001 · Cited by 102
Huang, Y., Hu, L., HUANG, S. H., Xu, W., Wan, J., Wang, D., Zheng, G., & Xia, Z. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s184379 · Cited by 96
Lübtow, M. M., Nelke, L. C., Seifert, J., Kühnemundt, J., Sahay, G., Dandekar, G., Nietzer, S. L., & Luxenhofer, R. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.014 · Cited by 85
Sadeghianmaryan, A., Yazdanpanah, Z., Soltani, Y. A., Sardroud, H. A., Nasirtabrizi, M. H., & Chen, X. (2020) · Journal of Biomaterials Science, Polymer Edition · doi:10.1080/09205063.2019.1680928 · Cited by 85
Defueling the cancer: ATP synthase as an emerging target in cancer therapy
Wang, T., Ma, F., & Qian, H. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.08.015 · Cited by 91
“Curcumin This MAS inhibitor is a natural polyphenol extracted from the roots and stalks of Zingiberaceae Curcuma longa, an herbal medicine with antitumor activity.(62,119) It inhibits many cancers, including liver cancer, breast cancer, cervical carcinoma, prostatic cancer, and lung cancer.”
BackgroundThe Polypharmacology of Natural Products
Ho, T. T., Tran, Q. T. N., & Chai, C. L. L. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0294 · Cited by 87
George, P., Das, R. K., & Chowdhury, P. (2019) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2019.02.028 · Cited by 88
Protein Carbonylation and Lipid Peroxidation in Hematological Malignancies
Rodríguez-García, A., García-Vicente, R., Morales, M. L., Ortiz-Ruiz, A., Martínez‐López, J., & Linares, M. (2020) · Antioxidants · doi:10.3390/antiox9121212 · Cited by 97
Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action
Talib, W. H., Al-hadid, S. A., Ali, M. B. W., Al-Yasari, I. H., & Ali, M. R. A. (2018) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s167812 · Cited by 93
“longa or turmeric is cultivated widely in India and contains 60–70% of curcumin ([1E,6E]-1,7-bis[4-hydroxy3-methoxyphenyl]-1,6-heptadiene-3,5-dione; Figure 1).(41,43) Researchers found that curcumin has many biological activities due to the huge chemical diversity of its metabolites.”
BackgroundA critical review of analytical methods for determination of curcuminoids in turmeric
Venkata, S. K., Satyabanta, L., & Goswami, T. K. (2019) · Journal of Food Science and Technology · doi:10.1007/s13197-019-03986-1 · Cited by 97
Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers
Ashrafizadeh, M., Zarrabi, A., Hashemipour, M., Vosough, M., Najafi, M., Shahinozzaman, M., Hushmandi, K., Khan, H. Z., & Mirzaei, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105199 · Cited by 87
Su, J., Cai, Y., Zhi, Z., Guo, Q. Q., Mao, L., Gao, Y., Yuan, F., & der Meeren, P. V. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117446 · Cited by 85
Neuroprotective Effects of Curcumin in Cerebral Ischemia: Cellular and Molecular Mechanisms
Subedi, L., & Gaire, B. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00153 · Cited by 90
Stem Cell-Based Therapy for Diabetic Foot Ulcers
Yu, Q., Qiao, G.-H., Wang, M., Li, Y., Sun, Y., Shi, H., & Ma, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.812262 · Cited by 87
Recent advances of analogues of curcumin for treatment of cancer
Zhao, S., Pi, C., Ye, Y., Zhao, L., & Wei, Y. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.034 · Cited by 87
Small molecules as inhibitors of PCSK9: Current status and future challenges
Xu, S., Luo, S., Zhu, Z., & Xu, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.011 · Cited by 85
Dong, L., He, J., Luo, L., & Wang, K. (2023) · Pharmaceuticals · doi:10.3390/ph16010092 · Cited by 86
Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles
Hu, Y., Li, M., Zhang, M., & Jin, Y. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.031 · Cited by 85
Rainey, N. E., Moustapha, A., & Petit, P. X. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3656419 · Cited by 85
“Medicinal chemists warned us about curcumin’s status not only as a PAINS but also as an AIC (assay interference compound) and an IMP (invalid/improbable metabolic panacea) status) [197] which has led to divisions within the scientific community [198, 199].”
BackgroundNano‐Derived Therapeutic Formulations with Curcumin in Inflammation‐Related Diseases
Quispe, C., Martins, N. A., Manca, M. L., Manconi, M., Sytar, O., Hudz, N., Shanaida, M., Kumar, M., Taheri, Y., Martorell, M., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3149223 · Cited by 90
“longa) rhizomes and less often in other Curcuma species [1, 10, 32, 33].”
BackgroundCharacterization of diarylheptanoids: An emerging class of bioactive natural products
Alberti, Á., Riethmüller, E., & Béni, S. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.08.051 · Cited by 88
Yin, J., Wang, L., Wang, Y., Shen, H., Wang, X., & Wu, L. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s199601 · Cited by 83
“However, its main limitation is rapid system elimination, decreased viability at alkaline pH and limited oral bioavailability.(29) Therefore, in order to overcome these limitations, how to increase its water solubility, stability, oral bioavailability and control and targeted administration will be further studied.”
BackgroundDolatabadi, S., Karimi, M., Nasirizadeh, S., Hatamipour, M., Golmohammadzadeh, S., & Jaafari, M. R. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102352 · Cited by 95
The ethnopharmacological literature: An analysis of the scientific landscape
Yeung, A. W. K., Heinrich, M., Kijjoa, A., Tzvetkov, N. T., & Atanasov, A. G. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112414 · Cited by 89
“512 Results obtained through in vitro and in vivo models is often not replicated in clinical trials, for 513 example, the case of curcumin (Nelson et al., 2017).”
BackgroundLi, S., Jin, M., Wu, Y., Jung, S., Li, D., He, N., & Lee, M. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1934189 · Cited by 81
“occurring in turmeric roots, with proven pharmacological activities, including anti-inflammatory, anti-bacterial, antiviral, anti-tumor, anti-ulcer, immunomodulatory, and neuroprotective effects (Liu et al., 2016; Nelson et al., 2017; Di Meo et al., 2019).”
BackgroundModulating the masters: chemical tools to dissect CBP and p300 function
Breen, M. E., & Mapp, A. K. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.005 · Cited by 87
Shafabakhsh, R., Mobini, M., Raygan, F., Aghadavod, E., Ostadmohammadi, V., Amirani, E., Mansournia, M. A., & Asemi, Z. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.09.029 · Cited by 81
Cheng, Y., Hsieh, C.-H., & Tsai, T. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.01.003 · Cited by 91
“[45] Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters M.”
BackgroundElbaz, N. M., Owen, A., Rannard, S. P., & McDonald, T. O. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118866 · Cited by 80
Metadata
- Authors
- Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A.
- Affiliations
- University of Minnesota (US)
- Brigham and Women's Hospital (US)
- University of Illinois Chicago (US)
- Corresponding author
- Walters, Michael A.
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-01-11
- Volume
- 60
- Issue
- 5
- Pages
- 1620-1637
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC5346970
- OpenAlex
- W2579340176
- Cited by
- 1,956
- References
- 153
- Citations by year
- 2026: 177 · 2025: 213 · 2024: 204 · 2023: 233 · 2022: 244 · 2021: 257 · 2020: 211 · 2019: 183 · 2018: 157 · 2017: 75
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by-nc-nd)
- University of Illinois Chicago
- Funders
- Office of Dietary Supplements (U41AT008706)
- National Center for Complementary and Integrative Health (U41AT008706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Saffron Plant Research Studies
- Keywords
- curcumin, curcuminoids, turmeric, medicinal chemistry, PAINS, IMPS, bioavailability, clinical trials
- MeSH terms
- Animals, Chemistry, Pharmaceutical, Curcumin, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.